Amgen has agreed to a $74 million settlement with investors who allege that the company hid a massive U.S. tax bill from the ...

Detailed phase 3 results suggest the two-drug combination of Gilead Sciences’ lenacapavir and Merck & Co.’s islatravir has ...

Novo Nordisk has accused Eli Lilly of running ad campaigns containing “deliberately false” messages that mislead the public ...

Following an inspection earlier this year that yielded a Form 483, Indian generics juggernaut Alembic Pharmaceuticals has ...

Novartis' CEO remains unfazed by the threat of a newly approved oral PCSK9 inhibitor in Merck & Co.’s Lipfendra, doubling ...

South Korean contract manufacturer Samsung Biologics hopes to tap into the booming peptide production and weight loss market with plans to buy out Switzerland-based CDMO PolyPeptide for 1.46 billion ...

On paper, it was another strong quarter for Carvykti. Johnson & Johnson reported record sales for the CAR-T therapy, ...

The campaign is one of weight loss app Noom's largest brand investment to date and features two TV spots and new in-app ...

After nearly a century of naming its Person of the Year each December, Time is adding another prestigious recognition with help from Johnson & Johnson. J&J and Time are teaming up to honor a ...

From Indiana to Iceland, the FDA this week disclosed concerns raised during recent visits to a pair of manufacturing sites ...

Since reaching the market a decade ago, PCSK9 inhibitors have not lived up to their lofty expectations. | The FDA has ...

Pacira BioSciences, Inc., an innovative biopharmaceutical company, focuses on non-opioid therapies that address a diverse range of musculoskeletal pain needs, including chronic and post-surgery pain.